OPC-34712

Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects

A Long-term Trial of OPC-34712 in Patients With Schizophrenia

A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia

Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)

Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia

Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder

Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects

Multicenter, Open-label, Safety and Tolerability Study

Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia

A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects

Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712